Aleksic M, Wolf B, Ulrich B
Chirurgische Klinik, Krankenhaus Gerresheim, Kliniken, Stadt Düsseldorf.
Chirurg. 1995 Dec;66(12):1247-53.
From January 1987 until December 1994 103 patients were treated for esophageal cancer in our department. Operability was 77.7%, 75.7% were resected. Postoperative lethality was 9.0% within 30 days and 16.7% for the whole hospital stay. Concerning the resected patients 37.5% adenocarcinoma and 60.0% squamous cell carcinoma were found. The most common localisation of the tumor was the lower third of the esophagus (62.5%). 35.9% underwent an abdominothoracic resection whereas in 64.1% a transhiatal esophagectomy was carried out. The UICC-stage distribution was as follows: I 11.3%, IIa 10.0%, IIb 12.5%, III 40.0%, IV 26.3%. In 79.2% of the cases lymph node metastasis were already recognizable. The median survival time was 10 (3-72) months with better outcome for adenocarcinoma, lymph node negative patients and early tumor stages. Even if only palliation was the aim of the surgical procedure esophagectomy followed by collar esophagogastrostomy provides satisfying results to regain the ability to swallow.
1987年1月至1994年12月，我科共治疗食管癌患者103例。可手术率为77.7%，切除率为75.7%。术后30天内死亡率为9.0%，住院期间总死亡率为16.7%。在切除的患者中，腺癌占37.5%，鳞状细胞癌占60.0%。肿瘤最常见的部位是食管下段（62.5%）。35.9%的患者接受了胸腹联合切除术，64.1%的患者进行了经裂孔食管切除术。UICC分期分布如下：I期11.3%，IIa期10.0%，IIb期12.5%，III期40.0%，IV期26.3%。79.2%的病例已有淋巴结转移。中位生存时间为10（3 - 72）个月，腺癌、淋巴结阴性患者及肿瘤早期患者预后较好。即使手术目的仅为缓解症状，食管切除术后行套入式食管胃吻合术也能取得令人满意的恢复吞咽功能的效果。
